Monday, March 17, 2025 | 01:54 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

NCLT reserves order in Sterling Biotech over settlement issue

Section 29A of IBC says the promoters of the debt-ridden company, which is facing insolvency proceeding, cannot bid for the company

Sterling Biotech
Premium

Subrata Panda Mumba
Attempt to withdraw the insolvency proceedings against Sterling Biotech by committee of creditors did not materialize and the National Company Law Tribunal reserved its order in the matter and listed the matter for hearing on April 26.

The bench presided over by V.P.Singh and Ravikumar Duraisamy questioned the motive of the bankers who have accepted the one time settlement offer by the committee of creditors because granting the plea that the bankers have made would mean the absconding promoter of the company would get back the company with a clean balance sheet.

But, Section 29 A of Insolvency and Bankruptcy code says

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in